
8.05 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 7.00 Today|||52-Week Range 26.55 | -61.75% Year-to-Date |
Travere (TVTX) Slumps 41% on Mixed Results From IgAN Drug Study Sep 22 / Zacks.com - Paid Partner Content | Xoma (XOMA) Moves 7.7% Higher: Will This Strength Last? Sep 18 / Zacks.com - Paid Partner Content |
Why Shares of Travere Therapeutics Are Slumping Thursday Sep 21 / MotleyFool.com - Paid Partner Content |
Previous close | 7.85 |
Today’s open | 7.76 |
Day’s range | 7.55 - 8.06 |
Volume | 121,211 |
Average volume (3 months) | 1,341,174 |
Market cap | $590.3M |
Earnings growth (last year) | -45.11% |
Earnings growth (this year) | +4.12% |
Earnings growth (next 5 years) | +37.50% |
Revenue growth (last year) | -6.80% |
P/E ratio | NM |
Price/Sales | 6.32 |
Price/Book | 11.81 |
Today’s change | Today’s % change | |
---|---|---|
RAPTRapt Therapeutics In... | -0.10 | -0.58% |
CDMOAvid Bioservices Inc | +0.09 | +0.94% |
ALECAlector Inc | +0.09 | +1.38% |
ALLOAllogene Therapeutic... | -0.17 | -4.51% |
Next reporting date | November 2, 2023 |
EPS forecast (this quarter) | -$1.02 |
Annual revenue (last year) | $212.0M |
Annual profit (last year) | -$278.5M |
Net profit margin | -131.35% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |